Literature DB >> 17889979

Retinal dysfunctions in schizophrenia.

Zita Balogh1, György Benedek, Szabolcs Kéri.   

Abstract

The purpose of this study was to investigate the earliest stages of visual information processing using electroretinography (ERG) in patients with schizophrenia and bipolar disorder and to compare these values with those of healthy control volunteers. In the acute stage of the illness, patients with schizophrenia exhibited decreased a-wave amplitude (a measure of photoreceptor function) as compared with healthy controls. In patients with bipolar disorder, ERG measures were intact. At the baseline assessment, there was a significant negative relationship between a-wave amplitude and positive symptoms. After an 8-week follow-up period, clinical symptoms showed significant improvement and the amplitude of the a-wave significantly increased in patients with schizophrenia. At the follow-up assessment, there was no significant difference between patients with schizophrenia and controls. These results indicate that retinal dysfunctions are specific for schizophrenia, as compared with bipolar disorder, and are confined to the acute stage of the illness.

Entities:  

Mesh:

Year:  2007        PMID: 17889979     DOI: 10.1016/j.pnpbp.2007.08.024

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  24 in total

1.  Electoretinographic evidence of retinal ganglion cell-dependent function in schizophrenia.

Authors:  Pantea Moghimi; Nathalia Torres Jimenez; Linda K McLoon; Theoden I Netoff; Michael S Lee; Angus MacDonald; Robert F Miller
Journal:  Schizophr Res       Date:  2019-10-12       Impact factor: 4.939

2.  From Imaging the Brain to Imaging the Retina: Optical Coherence Tomography (OCT) in Schizophrenia.

Authors:  Carlos Schönfeldt-Lecuona; Thomas Kregel; Arno Schmidt; Elmar H Pinkhardt; Florian Lauda; Jan Kassubek; Bernhard J Connemann; Roland W Freudenmann; Maximilian Gahr
Journal:  Schizophr Bull       Date:  2015-06-05       Impact factor: 9.306

3.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

4.  Full-field electroretinogram in autism spectrum disorder.

Authors:  Paul A Constable; Sebastian B Gaigg; Dermot M Bowler; Herbert Jägle; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2016-02-11       Impact factor: 2.379

5.  Issues in the Aggregation of Data on Retinal Structure and Function in Schizophrenia.

Authors:  Steven M Silverstein
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

6.  Deficient visual sensitivity in schizotypal personality disorder.

Authors:  Brendon W Kent; Zachary A Weinstein; Vincent Passarelli; Yue Chen; Larry J Siever
Journal:  Schizophr Res       Date:  2010-06-11       Impact factor: 4.939

7.  Nonconscious and conscious color priming in schizophrenia.

Authors:  Carol Jahshan; Jonathan K Wynn; Bruno G Breitmeyer; Michael F Green
Journal:  J Psychiatr Res       Date:  2012-07-10       Impact factor: 4.791

Review 8.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

9.  Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: A preliminary study.

Authors:  Deepthi Bannai; Paulo Lizano; Megan Kasetty; Olivia Lutz; Victor Zeng; Suraj Sarvode; Leo A Kim; Scot Hill; Carol Tamminga; Brett Clementz; Elliot Gershon; Godfrey Pearlson; John B Miller; Matcheri Keshavan
Journal:  Psychiatry Res Neuroimaging       Date:  2020-02-29       Impact factor: 2.376

10.  Retinal Changes in Schizophrenia: A Systematic Review and Meta-analysis Based on Individual Participant Data.

Authors:  Charalampos T Kazakos; Vasilios Karageorgiou
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.